Ohashi, K., Sequist, L. V., Moran, T., Chmielecki, J., Lin, Y.-L., Pan, Y., Wang, L., de Stanchina, E., Shien, K., Aoe, K.,
Toyooka, S., Kiura, K., Fernandez-Cuesta, L., Fidias, P., Yang, J.-C.-H., Miller, V. A., Riely, G. J., Kris, M. G., Engelman,
J. A., Vnencak-Jones, X. L., Dias-Santagata, D., Ladanyi, M., & Pao, W. (2012).
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS,
NRAS, or MEK1. Proceedings of the National Academy of Sciences of the United States of America,
109(31), E2127-E2133. doi:10.1073/pnas.1203530109.
